Is ATHA A Good Stock To Buy According To Hedge Funds?
A whopping number of 13F filings filed with U.S.
Athira Pharma Inc. (ATHA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 5,402,964 | $2,409,722 | 0.05% | |
| 2. | Propel Bio Management Leen Kawas And Richard Kayne | 1,492,792 | $665,785 | 0.38% | |
| 3. | Tang Capital Management Kevin C. Tang | 600,000 | $267,600 | -44% | 0.01% |
| 4. | Renaissance Technologies Jim Simons | 452,787 | $201,943 | +67% | 0% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 337,600 | $150,570 | -7% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.42 | 27,400 | 80,715 | 2024-06-24 | Filing | ||
| $2.26 | 15,000 | 53,315 | 2024-06-21 | Filing | ||
| $2.38 | 163,954 | Large Shareholder, Director | 5,402,964 | 2023-12-29 | Filing | |
| $2.44 | 409,598 | Large Shareholder, Director | 5,239,010 | 2023-12-28 | Filing | |
| $2.28 | 32,134 | Large Shareholder, Director | 4,829,412 | 2023-12-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.57 | 1,272 | 97,532 | 2024-09-05 | Filing | ||
| $0.57 | 2,525 | 20,870 | 2024-09-05 | Filing | ||
| $0.57 | 2,525 | 92,684 | 2024-09-05 | Filing | ||
| $0.57 | 2,525 | 51,927 | 2024-09-05 | Filing | ||
| $0.57 | 5,032 | 159,365 | 2024-09-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,698,453 | $4,127,241 | 0% | |
| 2. | 1,492,792 | $3,627,485 | 0.32% | |
| 3. | 1,454,362 | $3,534,100 | 2.67% | |
| 4. | 662,662 | $1,610,269 | 0% | |
| 5. | 372,296 | $904,680 | 0% |
News See All
Billionaire Hedge Funds
